Kaposi`s sarcoma in an Ankylosing Spondylitis patient treated with Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy

Authors : Selda HAKBİLEN, Dilek TEZCAN, Sema YİLMAZ

Pages : 49-53

Doi:10.46310/tjim.945846

View : 21 | Download : 12

Publication Date : 2022-01-29

Article Type : Other Papers

Abstract :Tumor necrosis factor-alpha insert ignore into journalissuearticles values(TNF-α); inhibitors are immunosuppressive agents used in a variety of inflammatory diseases, including rheumatoid arthritis insert ignore into journalissuearticles values(RA);, spondyloarthritis, psoriasis, and inflammatory bowel disease insert ignore into journalissuearticles values(IBD);. Kaposi’s sarcoma insert ignore into journalissuearticles values(KS); is an angioproliferative disease associated with the human herpes virus 8 insert ignore into journalissuearticles values(HHV-8);. We present a 46-year-old male patient with ankylosing spondylitis insert ignore into journalissuearticles values(AS); treated with TNF-α inhibitor and developed KS during follow-up. The coexistence of anti-TNF-α treatment with KS is a rare condition. This case is presented to address this rare association. Therefore, keeping in mind KS, which is a type of skin tumor, in such HIV-negative patients in whom immunosuppressive agents are initiated, is essential in terms of early diagnosis, treatment, and prevention of complications.
Keywords : Tumor necrosis factor alpha inhibitors, Kaposi, ankylosing spondylitis